Evaluation Of Functional Protein Molecules In Treating Obesity
Funder
National Health and Medical Research Council
Funding Amount
$349,407.00
Summary
This project aims to reduce excessive food consumption by controlling the satisfaction that people get from eating. This will be achieved through varying protein supplements (whey, leucine and beta-conglycinin) and their combinations. The idea is that people will feel satisfied despite eating less, leading to weight loss and the correction of related metabolic disorders.
Investigating The Physiological And Clinical Differences In Weight Loss In Obese Subjects With And Without Diabetes.
Funder
National Health and Medical Research Council
Funding Amount
$101,726.00
Summary
Obesity and type 2 diabetes are linked by the production of inflammatory factors in the body. These factors seem to link weight gain, especially around the abdomen, not only with insulin resistance, the precursor to diabetes, but also independently with the development with heart and kidney disease and reduced fertility. This study will investigate the effect of dieting and weight loss on inflammation and the function of the heart and other organs in obese people with and without diabetes.
Impact Of Beta Adrenergic Antagonsim On Energy Metabolism And Body Composition
Funder
National Health and Medical Research Council
Funding Amount
$118,557.00
Summary
Beta-blockers are drugs commonly used to treat high blood pressure, anxiety, migraines and irregular heart rhythms. They work by blocking the action of chemical messengers called catecholamines which increase metabolic rate, fat utilisation and heart function. The aim is to determine whether ?-blockers impair metabolic function of the body which may lead to obesity and a loss of fitness. Judicious use of these medications and consideration of alternatives may lead to better health outcomes.
Dilinoleoyl Phosphatidic Acid As A Novel Mediator Of Insulin Resistance In Muscle
Funder
National Health and Medical Research Council
Funding Amount
$504,097.00
Summary
We have identified a novel fat molecule in muscle which may play an important role in causing insulin resistance during obesity, a major factor in the development of Type 2 diabetes. We will now examine whether depletion of this molecule, dilinoleoyl-phosphatidic acid, can improve insulin action in muscles and in obese mice, and investigate the mechanisms by which it may act. This work may indicate new strategies for the treatment of diabetes.
Regulation Of Growth Hormone Action By Sex Steroids: Metabolic Implications For Health And Disease
Funder
National Health and Medical Research Council
Funding Amount
$353,250.00
Summary
Fitness and health is determined by body composition, the amount of fat and lean tissue in the body. Obesity increases the risk of diabetes, blood pressure and heart attacks, while muscle wasting reduces strength and fitness. Body composition is controlled by hormones such as growth hormone (GH) which reduces body fat by stimulating its metabolism (burning) and increases lean tissue by stimulating protein synthesis. These metabolic actions of GH are exerted through the liver. This proposal seeks ....Fitness and health is determined by body composition, the amount of fat and lean tissue in the body. Obesity increases the risk of diabetes, blood pressure and heart attacks, while muscle wasting reduces strength and fitness. Body composition is controlled by hormones such as growth hormone (GH) which reduces body fat by stimulating its metabolism (burning) and increases lean tissue by stimulating protein synthesis. These metabolic actions of GH are exerted through the liver. This proposal seeks to understand how sex hormones control the amount of body fat and muscle in women and men. Based on previous research in our laboratory, we propose that sex hormones control the action of growth hormone on the liver. We will test the hypothesis that oestrogens impair the ability of the liver to burn fat and build protein in response to GH while male hormones have the opposite effect. The effect of oestrogen occurs only when oestrogen is taken as a tablet because the liver is exposed to high concentrations of this hormone after gut absorption. It causes postmenopausal women to gain fat and lose muscle. Apart from oestrogens, there are many other compounds with oestrogen-like activities such as phytooestrogens (oestrogens found in plants) and SERMs (used for treating osteoporosis). Their effect on the liver and body composition are unknown but important because of their widespread use in the community. The significance of these studies relate to optimising the benefits of oestrogen compounds by defining their metabolic effects on the liver. In men, understanding how male hormones work as anabolic agents may lead to ways of treating protein muscle wasting.Read moreRead less
Oestrogens And The Metabolic Process: Regulatory Interaction With The GH-IGF-system In Health And Disease
Funder
National Health and Medical Research Council
Funding Amount
$547,970.00
Summary
Growth hormone (GH) plays a key role in controlling body metabolism, fat and muscle in adult life. The female hormone oestrogen controls how much GH is secreted and how well it acts. Drugs that act like or interfere with the action of oestrogen are used increasing for the treatment of many conditions e.g. growth, cancer and osteoporosis. This proposal examines their impact on cardiovascular and physical health.
Interactions Between Fetal Programming And Postnatal Diet In Development Of The Metabolic Syndrome
Funder
National Health and Medical Research Council
Funding Amount
$445,578.00
Summary
More than 50,000 Australians die annually from cardiovascular disease, accounting for almost 40% of all deaths. Obesity and high blood pressure are both key risk factors for cardiovascular disease, and so it is crucial that we understand the underlying causes of these conditions and how lifestyle changes, such as diet, can prevent them. We now know that several adult-onset diseases, including high blood pressure, obesity and diabetes, are influenced by how well we grow and develop as a fetus. Th ....More than 50,000 Australians die annually from cardiovascular disease, accounting for almost 40% of all deaths. Obesity and high blood pressure are both key risk factors for cardiovascular disease, and so it is crucial that we understand the underlying causes of these conditions and how lifestyle changes, such as diet, can prevent them. We now know that several adult-onset diseases, including high blood pressure, obesity and diabetes, are influenced by how well we grow and develop as a fetus. This effect, known as 'fetal programming', means that if we have a poor environment as a fetus (eg, maternal undernutrition), we are more likely to develop health problems such as high blood pressure many years later. In this study we are interested in how the events in fetal life 'program' these later health problems, and how we might reverse the adverse effects by lifestyle changes after birth. We have developed an animal model in which high blood pressure and problems with fat and muscle function that can lead to obesity and diabetes. These detrimental effects on adult health can be completely prevented in our model by placing offspring on a diet rich in omega-3 fats from the time of birth. These fats are commonly found in fish oil and are well known for their beneficial effects on cardiovascular function. The present proposal will extend these findings by determining whether omega-3 fatty acids can reverse the adverse programming outcomes after they have emerged in adult life. We will also investigate whether fetal programming effects are made even worse by the consumption of excess total dietary fat during development to adulthood, and if this effect can also be overcome by supplementation of the diet with omega-3 fats.Read moreRead less
Leptin And The Regulation Of Substrate Partitioning
Funder
National Health and Medical Research Council
Funding Amount
$349,876.00
Summary
The prevalence of obesity is increasing with currently 18% of adult Australians being classified as obese. Obesity, particularly abdominal obesity, is associated with high blood lipid levels and blood pressure, and type 2 diabetes. In Australia, the cost of obesity is estimated to be $830 million per year. The ultimate aim of any obesity treatment programme is to reduce body fatness by burning off fat and to prevent further fat storage and so studies which focus on developing strategies to achie ....The prevalence of obesity is increasing with currently 18% of adult Australians being classified as obese. Obesity, particularly abdominal obesity, is associated with high blood lipid levels and blood pressure, and type 2 diabetes. In Australia, the cost of obesity is estimated to be $830 million per year. The ultimate aim of any obesity treatment programme is to reduce body fatness by burning off fat and to prevent further fat storage and so studies which focus on developing strategies to achieve these goals are very important. We have found that subjects who fail to keep weight off after being on a weight-reducing diet are bad fat burners. These people also have low levels of leptin, a hormone made by fat cells which helps to regulate food intake. The first aim of this study is to show that leptin increases the burning of fat by regulating the production and activity of factors which decide whether fat is used for energy or is stored in the body. The second aim is to find ways in which leptin levels can be changed so that fat burning is increased. Some of the ways in which we will change leptin levels are by changing the fat content of the diet, or by drugs, or by giving leptin itself. These studies will be performed in animal models of obesity and will help us to develop strategies for the treatment and prevention of obesity in humans.Read moreRead less